BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Addrenex Pharmaceuticals (Acquired by Sciele Pharma) 

Press releases archived for reference only.

Morrisville  North Carolina    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Sciele Pharma, Inc. (SCRX), a Shionogi & Co., Ltd. Company, to Acquire Addrenex Pharmaceuticals, a U.S. Specialty Pharmaceutical Company 11/16/2009 10:36:14 AM
Addrenex Pharmaceuticals Announces Licensing Agreement With Dream Pharma 8/5/2009 9:31:00 AM
Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy 5/13/2009 8:34:30 AM
Sciele Pharma, Inc. (SCRX) and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel Used in Combination with Stimulants to Treat ADHD 4/23/2009 12:10:00 PM
Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication 4/23/2009 9:13:10 AM
Sciele Pharma, Inc. (SCRX) Announces That Addrenex Pharmaceuticals Initiates Phase II Clinical Trial of ADX415 for the Treatment of Hypertension 10/23/2008 2:02:21 PM
Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415 10/23/2008 9:56:05 AM
Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD 9/11/2008 6:34:05 AM
Sciele Pharma, Inc. (SCRX) and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel for ADHD 9/10/2008 12:28:06 PM
Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 8/20/2008 7:29:45 AM
12